Regis B. Kelly
Directeur/Bestuurslid bij Bay Area Council Economic Institute
Profiel
Regis B.
Kelly is currently the Director at Bay Area Council Economic Institute, Director at San Francisco-Bangalore Sister City Committee, Venture Partner at Medical Technology Venture Partners, and Advisor at Impact Science Ventures.
He was previously the Director at Nitrase Therapeutics, Inc. and the Managing Partner at Mission Bay Capital Management, Inc. Kelly received his undergraduate degree from The University of Edinburgh in 1961 and his doctorate degree from California Institute of Technology in 1967.
Actieve functies van Regis B. Kelly
| Bedrijven | Functie | Begin |
|---|---|---|
Bay Area Council Economic Institute
 Bay Area Council Economic Institute Miscellaneous Commercial ServicesCommercial Services Bay Area Council Economic Institute operates an advocacy and research organization. The firm's services include infrastructure, trade, globalization, science and innovation, business development and governance. The company is headquartered in San Francisco, CA. | Directeur/Bestuurslid | - |
Medical Technology Venture Partners
 Medical Technology Venture Partners Investment ManagersFinance Medical Technology Venture Partners (MedTech Venture Partners) is a venture capital firm founded by Radu Cautis and Thomas Heinrich Glanzmann in 2017. The firm is headquartered in San Francisco, California. | Private Equity Investor | - |
| San Francisco-Bangalore Sister City Committee , Inc. | Directeur/Bestuurslid | - |
Impact Science Ventures
 Impact Science Ventures Investment ManagersFinance Impact Science Ventures (Impact Science Ventures) is a venture capital firm founded in 2021 by Robert Ethier, Alain Harrus and Kiang Meng Hsiung. The firm is headquartered in San Francisco, California. | Consultant / Adviseur | - |
Eerdere bekende functies van Regis B. Kelly
| Bedrijven | Functie | Einde |
|---|---|---|
Nitrase Therapeutics, Inc.
 Nitrase Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nitrase Therapeutics, Inc. develops drugs against newly discovered nitration enzyme. The firm provides disease modifying drugs for multiple additional aging-dependent diseases, such as neurodegenerative disease, heart disease and cancer. The company was founded by Irene Griswold-Prenner and is headquartered in Jackson, WY. | Directeur/Bestuurslid | - |
Mission Bay Capital Management, Inc.
 Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California. | Chief Investment Officer | - |
Opleiding van Regis B. Kelly
| The University of Edinburgh | Undergraduate Degree |
| California Institute of Technology | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Bay Area Council Economic Institute
Bay Area Council Economic Institute Miscellaneous Commercial ServicesCommercial Services Bay Area Council Economic Institute operates an advocacy and research organization. The firm's services include infrastructure, trade, globalization, science and innovation, business development and governance. The company is headquartered in San Francisco, CA. | Commercial Services |
Mission Bay Capital Management, Inc.
Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California. | Finance |
Medical Technology Venture Partners
Medical Technology Venture Partners Investment ManagersFinance Medical Technology Venture Partners (MedTech Venture Partners) is a venture capital firm founded by Radu Cautis and Thomas Heinrich Glanzmann in 2017. The firm is headquartered in San Francisco, California. | Finance |
Nitrase Therapeutics, Inc.
Nitrase Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nitrase Therapeutics, Inc. develops drugs against newly discovered nitration enzyme. The firm provides disease modifying drugs for multiple additional aging-dependent diseases, such as neurodegenerative disease, heart disease and cancer. The company was founded by Irene Griswold-Prenner and is headquartered in Jackson, WY. | Commercial Services |
Impact Science Ventures
Impact Science Ventures Investment ManagersFinance Impact Science Ventures (Impact Science Ventures) is a venture capital firm founded in 2021 by Robert Ethier, Alain Harrus and Kiang Meng Hsiung. The firm is headquartered in San Francisco, California. | Finance |
| San Francisco-Bangalore Sister City Committee , Inc. |